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G protein-coupled receptors
• 60% of all drugs target GPCR’s 






























release of cytokines-TNFa, IL-1
T-lymphocyte proliferation
IgG production






Complement Factor 5a and Inflammatory Disease
C5a
174
Antagonist Mimics Helical Turn of C5a
3D53
Aims
• Synthesis and testing of analogues
• NMR structures of 3D53 and analogues
– Macrocycle shape
– Side chain locations (a-b, b-g vectors)
• Develop SAR of C5a antagonism
• Pharmacophore Development
Synthesis
• Solid Phase Peptide Synthesis for Analogues
• Solution Phase Scale-up for 3D53
• R.C. Reid, G. Abbenante, S.M. Taylor, and D.P. Fairlie; J. Org. Chem.; 2003; 68, pp 4464 - 4471






• 3 f restraints















• 3 f restraints










• 2 f restraints




























































– Macrocycle is moderately flexible
– Side chain positions independent of macrocycle 
shape
– Side chains key determinants of activity
• Pharmacophore Development
– 3 Hydrophobic residues on one face of 
macrocycle
– Bulky (Trp) residue key determinant of 
antagonism
– Arginine residue projected away from other 
binding residues
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